PLoS ONE (Jan 2015)

The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru.

  • Louis Grandjean,
  • Tomotada Iwamoto,
  • Anna Lithgow,
  • Robert H Gilman,
  • Kentaro Arikawa,
  • Noriko Nakanishi,
  • Laura Martin,
  • Edith Castillo,
  • Valentina Alarcon,
  • Jorge Coronel,
  • Walter Solano,
  • Minoo Aminian,
  • Claudia Guezala,
  • Nalin Rastogi,
  • David Couvin,
  • Patricia Sheen,
  • Mirko Zimic,
  • David A J Moore

DOI
https://doi.org/10.1371/journal.pone.0126271
Journal volume & issue
Vol. 10, no. 5
p. e0126271

Abstract

Read online

BackgroundThe comparison of Mycobacterium tuberculosis bacterial genotypes with phenotypic, demographic, geospatial and clinical data improves our understanding of how strain lineage influences the development of drug-resistance and the spread of tuberculosis.MethodsTo investigate the association of Mycobacterium tuberculosis bacterial genotype with drug-resistance. Drug susceptibility testing together with genotyping using both 15-loci MIRU-typing and spoligotyping, was performed on 2,139 culture positive isolates, each from a different patient in Lima, Peru. Demographic, geospatial and socio-economic data were collected using questionnaires, global positioning equipment and the latest national census.ResultsThe Latin American Mediterranean (LAM) clade (OR 2.4, pConclusionsTuberculosis disease caused by the LAM clade was more likely to be drug resistant independent of important clinical, genetic and socio-economic confounding factors. Explanations for this include; the preferential co-evolution of LAM strains in a Latin American population, a LAM strain bacterial genetic background that favors drug-resistance or the "founder effect" from pre-existing LAM strains disproportionately exposed to drugs.